BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24816171)

  • 21. HLA-A*0201-restricted CD8+ T-cell epitopes identified in dengue viruses.
    Duan ZL; Li Q; Wang ZB; Xia KD; Guo JL; Liu WQ; Wen JS
    Virol J; 2012 Nov; 9():259. PubMed ID: 23121866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A single nine-amino acid peptide induces virus-specific, CD8+ human cytotoxic T lymphocyte clones of heterogeneous serotype specificities.
    Zivny J; Kurane I; Leporati AM; Ibe M; Takiguchi M; Zeng LL; Brinton MA; Ennis FA
    J Exp Med; 1995 Sep; 182(3):853-63. PubMed ID: 7544398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functionality of dengue virus specific memory T cell responses in individuals who were hospitalized or who had mild or subclinical dengue infection.
    Jeewandara C; Adikari TN; Gomes L; Fernando S; Fernando RH; Perera MK; Ariyaratne D; Kamaladasa A; Salimi M; Prathapan S; Ogg GS; Malavige GN
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003673. PubMed ID: 25875020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of B cell epitopes of dengue virus 2 NS3 protein by monoclonal antibody.
    Tian Y; Chen W; Yang Y; Xu X; Zhang J; Wang J; Xiao L; Chen Z
    Appl Microbiol Biotechnol; 2013 Feb; 97(4):1553-60. PubMed ID: 23081772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.
    Mathew A; Townsley E; Ennis FA
    Future Microbiol; 2014; 9(3):411-25. PubMed ID: 24762312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential in vivo clearance and response to secondary heterologous infections by H2(b)-restricted dengue virus-specific CD8+ T cells.
    Beaumier CM; Jaiswal S; West KY; Friberg H; Mathew A; Rothman AL
    Viral Immunol; 2010 Oct; 23(5):477-85. PubMed ID: 20883162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice.
    Roth C; Cantaert T; Colas C; Prot M; Casadémont I; Levillayer L; Thalmensi J; Langlade-Demoyen P; Gerke C; Bahl K; Ciaramella G; Simon-Loriere E; Sakuntabhai A
    Front Immunol; 2019; 10():1424. PubMed ID: 31293584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inferring Protective CD8+ T-Cell Epitopes for NS5 Protein of Four Serotypes of Dengue Virus Chinese Isolates Based on HLA-A, -B and -C Allelic Distribution: Implications for Epitope-Based Universal Vaccine Design.
    Shi J; Sun J; Wu M; Hu N; Li J; Li Y; Wang H; Hu Y
    PLoS One; 2015; 10(9):e0138729. PubMed ID: 26381649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design.
    Ramírez R; Falcón R; Izquierdo A; García A; Alvarez M; Pérez AB; Soto Y; Muné M; da Silva EM; Ortega O; Mohana-Borges R; Guzmán MG
    Virus Genes; 2014 Oct; 49(2):185-95. PubMed ID: 24854144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dengue virus-specific, human CD4+ CD8- cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones.
    Kurane I; Brinton MA; Samson AL; Ennis FA
    J Virol; 1991 Apr; 65(4):1823-8. PubMed ID: 1705990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2Δ30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain.
    Grifoni A; Angelo M; Sidney J; Paul S; Peters B; de Silva AD; Phillips E; Mallal S; Diehl SA; Botten J; Boyson J; Kirkpatrick BD; Whitehead SS; Durbin AP; Sette A; Weiskopf D
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine.
    Ahmed SF; Quadeer AA; Barton JP; McKay MR
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008676. PubMed ID: 32956362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of murine CD8(+) T-cell clones specific for the Dengue virus NS3 protein: flavivirus cross-reactivity and influence of infecting serotype.
    Spaulding AC; Kurane I; Ennis FA; Rothman AL
    J Virol; 1999 Jan; 73(1):398-403. PubMed ID: 9847344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential humoral and cellular immunity induced by vaccination using plasmid DNA and protein recombinant expressing the NS3 protein of dengue virus type 3.
    Hurtado-Melgoza ML; Ramos-Ligonio A; Álvarez-Rodríguez LM; Meza-Menchaca T; López-Monteon A
    J Biomed Sci; 2016 Dec; 23(1):85. PubMed ID: 27903271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification.
    Pinto PBA; Assis ML; Vallochi AL; Pacheco AR; Lima LM; Quaresma KRL; Pereira BAS; Costa SM; Alves AMB
    Front Immunol; 2019; 10():1522. PubMed ID: 31333657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes.
    Gao G; Wang Q; Dai Z; Calcedo R; Sun X; Li G; Wilson JM
    Hum Gene Ther; 2008 Sep; 19(9):927-36. PubMed ID: 18788905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and immunogenicity of two new HLA-A*0201-restricted CD8+ T-cell epitopes on dengue NS1 protein.
    Tian J; Zeng G; Pang X; Liang M; Zhou J; Fang D; Liu Y; Li D; Jiang L
    Int Immunol; 2012 Apr; 24(4):207-18. PubMed ID: 22298881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.
    Liang H; Lee M; Jin X
    Cell Mol Immunol; 2016 Jan; 13(1):36-46. PubMed ID: 26435066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes.
    Weiskopf D; Angelo MA; Bangs DJ; Sidney J; Paul S; Peters B; de Silva AD; Lindow JC; Diehl SA; Whitehead S; Durbin A; Kirkpatrick B; Sette A
    J Virol; 2015 Jan; 89(1):120-8. PubMed ID: 25320311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8
    Wen J; Tang WW; Sheets N; Ellison J; Sette A; Kim K; Shresta S
    Nat Microbiol; 2017 Mar; 2():17036. PubMed ID: 28288094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.